✦ LIBER ✦
First-line bevacizumab (Avastin) with 5-fluorouracil/leucovorin prolongs progression-free survival in metastatic colorectal cancer (mCRC) patients who are not optimal candidates for irinotecan therapy. ASCO 2004: Abstract No. (3516)
✍ Scribed by F. Kabbinavar; J. Schulz; M. McCleod; T. Patel; J. Hamm; J. Hecht; B. Perrou; S. Griffing; B. Nelson; W. Novotny
- Book ID
- 117575733
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 99 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0753-3322
No coin nor oath required. For personal study only.